[go: up one dir, main page]

AU2013901917A0 - Compositions and methods for topical administration of vitamin B12 - Google Patents

Compositions and methods for topical administration of vitamin B12

Info

Publication number
AU2013901917A0
AU2013901917A0 AU2013901917A AU2013901917A AU2013901917A0 AU 2013901917 A0 AU2013901917 A0 AU 2013901917A0 AU 2013901917 A AU2013901917 A AU 2013901917A AU 2013901917 A AU2013901917 A AU 2013901917A AU 2013901917 A0 AU2013901917 A0 AU 2013901917A0
Authority
AU
Australia
Prior art keywords
vitamin
compositions
methods
topical administration
topical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2013901917A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2013901917A0 publication Critical patent/AU2013901917A0/en
Assigned to RUSSELL-JONES, GREGORY reassignment RUSSELL-JONES, GREGORY Request for Assignment Assignors: Boston Health Pty Ltd
Abandoned legal-status Critical Current

Links

AU2013901917A 2013-05-29 Compositions and methods for topical administration of vitamin B12 Abandoned AU2013901917A0 (en)

Publications (1)

Publication Number Publication Date
AU2013901917A0 true AU2013901917A0 (en) 2013-06-13

Family

ID=

Similar Documents

Publication Publication Date Title
IL274841A (en) Stabilized modified release vitamin d formulation and method of administering same
EP3030266A4 (en) Topical compositions and methods of using the same
IL240290A0 (en) Pyridazinone-amides derivatives and pharmaceutical compositions containing them
EP3082817A4 (en) Compositions for drug administration
EP3021843A4 (en) Anti-viral compounds, pharmaceutical compositions, and methods of use thereof
EP3038465A4 (en) Oral pharmaceutical formulation of omarigliptin
EP3060301A4 (en) Systems and methods for increased vitamin d3 production
EP3055281A4 (en) Preparation of hydroxy-benzylbenzene derivatives
EP3025720A4 (en) Preparation method for therapeutic agent of bead-type chondrocyte
EP3090746A4 (en) Pharmaceutical composition not containing antioxidant and preparation method therefor
EP3020417A4 (en) Pharmaceutical composition for respiratory administration
EP3003324A4 (en) Pharmaceutical compositions
EP3049077A4 (en) Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
GB201320932D0 (en) Topical pharmaceutical composition
EP3036008A4 (en) Compositions comprising vitamin b12 and intrinsic factor and methods of use thereof
PL3030319T3 (en) Compositions comprising vitamin k derivatives and salts
EP3080246A4 (en) Compositions and methods for producing and administering brown adipocytes
EP2958594A4 (en) Pharmaceutical composition for enhanced transmucosal administration of benzodiazepines
EP3057596A4 (en) Compositions and methods of administering same
EP3079721A4 (en) Pharmaceutical compositions of carotenoid
EP3043648A4 (en) Bendamustine pharmaceutical compositions
EP3019468A4 (en) Formulations for cathepsin k inhibitors with vitamin d
EP3092220A4 (en) Vitamin c prodrugs and uses thereof
AU2013901917A0 (en) Compositions and methods for topical administration of vitamin B12
EP3072873A4 (en) Vitamin d analogues of pharmaceutical interest